This is a routine employee share issuance with negligible dilution. No impact on fundamental valuation. Monitor upcoming earnings or pipeline catalysts for directional moves.
AZN drugs
AZN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 3 $157.97entry
- T+1 · 3mo ago −1.65%α −3.43% · $155.36
- T+5 · 3mo ago +2.30%α +0.27% · $161.61
- T+20 · 3mo ago +2.47%α +1.23% · $161.87
- T+60 · 20d ago +7.67%α +6.08% · $170.08
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
AstraZeneca filed a routine 6-K notification of admission of 8,855 ordinary shares under its employee share schemes, issued between 1 July and 31 July 2026 under a block admission from January 2021. The total shares outstanding increased to 1,551,033,389, representing negligible dilution of ~0.00057%. This is an administrative filing with no material impact on the company's financials or stock price.
Key Facts
- AstraZeneca admitted 8,855 ordinary shares under employee share schemes
- Total shares outstanding after admission: 1,551,033,389
- Issued between 1 July 2026 and 31 July 2026 under block admission dated 29 January 2021
Financial Impact
Immaterial - 8,855 shares issued under employee schemes, representing 0.00057% dilution on total shares outstanding of 1,551,033,389
Risk Factors
- No material risk from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (AZN), Batch item 1 | 0001654954-26-007169 |
| Document: 0001654954-26-007169-index-headers.html | 0001654954-26-007169 |
| Document: 0001654954-26-007169-index.html | 0001654954-26-007169 |
| Document: 0001654954-26-007169.txt | 0001654954-26-007169 |
| 6-K Filing (AZN), Batch item 5 | 0001654954-26-007169 |
| Document: 0001654954-26-007169-index-headers.html | 0001654954-26-007169 |
| Document: 0001654954-26-007169-index.html | 0001654954-26-007169 |
| Document: 0001654954-26-007169.txt | 0001654954-26-007169 |
Track record
77 reports on AZN
19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
- Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
- Nov 4, 202611d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
- Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers